Skip to content
karyopharm-logoLogo for Karyopharm
Main Menu
  • Contact
  • Clinical Trials
  • Careers
  • Follow Us
  • LinkedIn
  • Twitter
  • About
    • About Karyopharm
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Media Center
    • Events & Webinars
    • Careers
  • Patients & Families
    • Overview
    • Multiple Myeloma
    • SINE Technology
    • Diffuse Large B-Cell Lymphoma (DLBCL)
    • Clinical Trials
    • Patient Resources
  • Healthcare Professionals
    • SINE Technology (Selective Inhibitor of Nuclear Export)
    • Healthcare Provider Resources
    • Supporting Medical Research
    • Publications and Presentations
    • Grants and Giving
  • Products
  • Pipeline
    • Overview
    • Oral Selinexor
    • Oral Eltanexor
    • Oral Dual Inhibitor of PAK4 and NAMPT (KPT-9274)
    • Oral Verdinexor
    • Expanded Access
  • Investors
    • Company Overview
    • Events & Presentations
    • Corporate Governance
      • Management Team
      • Board of Directors
      • Committee Composition
      • Contact the Board
    • Financial Information
      • SEC Filings
      • Annual Reports & Proxy Statements
      • Quarterly Results
      • Key Ratios
    • Stock Information
      • Interactive Chart
      • Investment Calculator
      • Historical Stock Price
    • Analyst Coverage
    • Investor Alerts
    • Press Releases
    • Contact Us
      • Investor FAQs
      • RSS

Our Management Team

Michael G. Kauffman, MD, PhD
Michael G. Kauffman, MD, PhD
Chief Executive Officer, Karyopharm’s Founder
Shacham
Sharon Shacham, PhD, MBA
President and Chief Scientific Officer, Karyopharm’s Founder
Brian Austad, PhD
Brian Austad, PhD
Senior Vice President, Pharmaceutical Sciences
John Demaree, MBA
Chief Commercial Officer
Ran Frenkel, RPh
Ran Frenkel, RPh
EVP, Chief Development Officer
Karp large headshot
Ian Karp, MBA
Senior Vice President, Investor and Public Relations
Yosef Landesman, PhD
Senior Vice President, Research and Translational Medicine
Tanya Lewis, MS
Tanya Lewis, MS
Executive Vice President, Chief Regulatory and Quality Officer
Mike Mano, JD
Senior Vice President and General Counsel
Mike Mason
Michael Mason, MBA, CPA
Chief Financial Officer
Lisa Meletta, JD
Vice President, Legal & Chief Compliance Officer
Ronit Milstein, MBA
Ronit Milstein, MBA
Vice President, Operations
Stephen Mitchener, PharmD
Chief Business Officer
Anat Haas Mizrahi, LLB
Anat Haas Mizrahi, LLB
General Manager, Karyopharm Israel
Perry Monaco
Senior Vice President, Sales
Steven Rotman, MSc
Chief People and Corporate Engagement Officer
Pierre S. Sayad, PhD, MS
Vice President, Global Medical and Scientific Affairs
Jatin Shah, MD
Jatin Shah, MD
Executive Vice President, Chief Medical Officer
© Karyopharm, 2021. All Rights Reserved.
  • Terms of Use
  • Privacy Policy
  • Site Map